Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent. Illuccix claims to be the first prostate-specific membrane ...
Stockhead on MSN15h
Health Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agentBrazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix. ... Read ...
In a report released today, Shane Storey from Wilsons maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), with a ...
Pharmaceutical Technology on MSN5d
Telix’s new lead-212 generator could dispel medical isotope scalability hurdlesLead-212 is a promising radioactive isotope for use in targeted alpha therapy, an alternative modality to beta-particle-based ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...
Vietnam Investment Review on MSN14h
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin AmericaTelix Pharmaceuticals Limited today announces that the Brazilian Health Regulatory Agency has approved Illuccix® the ...
The high-flying S&P/ASX 200 Index (ASX: XJO) share made a major acquisition announcement. Here’s what you need to know.
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...
(MENAFN- GlobeNewsWire - Nasdaq) MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback